Kawthar Diab | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Prof. Dr. Kawthar Diab | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Research Professor at National Research Centre, Egypt

Prof. Dr. Kawthar Abdelaziz Elsayed Mohamed Diab is a distinguished Research Professor at the Genetics and Cytology Department, National Research Centre, Egypt. With a Ph.D. in Zoology from Ain Shams University, she specializes in genotoxicity, cancer pharmacology, and medicinal plant research. She has completed postdoctoral fellowships in Japan and India, contributing to cancer prevention and environmental toxicology studies. Dr. Diab has actively participated in numerous national and international research projects, serving as both a principal investigator and a key member. Her extensive peer-review contributions span leading scientific journals, including the British Journal of Pharmacology and ACS Omega. She possesses expertise in genotoxic assays, anticancer screening, and phytochemical analysis. Additionally, she has supervised Ph.D. candidates and presented at global conferences. With a prolific publication record and significant contributions to genetics and toxicology, Dr. Diab stands as a leading researcher dedicated to advancing biomedical and environmental health sciences.

Professional Profile 

Education

Prof. Dr. Kawthar Abdelaziz Elsayed Mohamed Diab holds a Ph.D. in Zoology from Ain Shams University, Egypt, where she conducted extensive research in genetics and cytology. Her academic journey began with a strong foundation in biological sciences, leading her to specialize in genotoxicity, cancer pharmacology, and environmental toxicology. To further enhance her expertise, she pursued postdoctoral research in Japan and India, focusing on cancer prevention, medicinal plant applications, and toxicological assessments. Throughout her educational career, she has actively engaged in interdisciplinary studies, integrating molecular biology, pharmacology, and cytogenetics. Her academic training has equipped her with advanced skills in genotoxic assays, phytochemical analysis, and anticancer drug screening. Dr. Diab’s commitment to continuous learning and international research collaborations has significantly contributed to her expertise in biomedical sciences, positioning her as a leading scholar in genetics and toxicology.

Professional Experience

Prof. Dr. Kawthar Abdelaziz Elsayed Mohamed Diab has an extensive professional background in zoology, genetics, and toxicology. She serves as a professor at Ain Shams University, Egypt, where she has been instrumental in advancing research on genotoxicity, cancer pharmacology, and environmental toxicology. With decades of academic and research experience, she has led numerous studies on the effects of medicinal plants, natural compounds, and toxic agents on genetic material. Her international collaborations include postdoctoral research in Japan and India, where she focused on cancer prevention and phytochemical applications. Dr. Diab has supervised numerous postgraduate students, contributed to scientific committees, and reviewed research for high-impact journals. As an expert in molecular biology and cytogenetics, she has played a vital role in bridging the gap between toxicological research and biomedical advancements. Her dedication to scientific excellence and education continues to shape the future of genetic and environmental health research.

Research Interest

Prof. Dr. Kawthar Abdelaziz Elsayed Mohamed Diab’s research interests span genetics, toxicology, cancer pharmacology, and environmental health. She focuses on genotoxicity studies, exploring the impact of environmental pollutants, pharmaceuticals, and natural compounds on genetic material. Her work delves into cancer prevention, particularly investigating the potential of medicinal plants and bioactive compounds in mitigating carcinogenesis. Dr. Diab is also engaged in molecular toxicology, assessing DNA damage, oxidative stress, and cellular responses to toxic agents. Her research extends to cytogenetics and molecular biology, where she examines chromosomal abnormalities and genetic mutations linked to disease progression. She has a keen interest in phytochemicals, exploring their therapeutic effects on genetic stability and disease prevention. Through her interdisciplinary approach, she aims to bridge toxicology, pharmacology, and genetics to develop innovative strategies for disease prevention and environmental health protection. Her contributions significantly advance the understanding of genetic and environmental risk factors in human health.

Award and Honor

Prof. Dr. Kawthar Abdelaziz Elsayed Mohamed Diab has received numerous awards and honors in recognition of her outstanding contributions to genetics, toxicology, and environmental health research. She has been honored for her groundbreaking work in genotoxicity and cancer pharmacology, earning prestigious accolades from national and international scientific organizations. Her dedication to advancing molecular toxicology and cytogenetics has been acknowledged through research excellence awards, distinguished scientist recognitions, and honorary memberships in esteemed scientific societies. She has also been invited as a keynote speaker at major conferences, where she has shared her expertise on genetic stability, phytochemicals, and environmental toxicants. Additionally, Dr. Diab has received grants and fellowships that support her innovative studies in pharmacogenomics and disease prevention. Her contributions to academia, research, and public health have positioned her as a leading scientist in her field, earning her widespread recognition and respect in the global scientific community.

Research Skill

Prof. Dr. Kawthar Abdelaziz Elsayed Mohamed Diab possesses a diverse and advanced set of research skills in genetics, toxicology, and environmental health sciences. She is highly skilled in molecular toxicology techniques, including DNA damage assessment, genotoxicity testing, and chromosomal aberration analysis. Her expertise extends to cytogenetic studies, where she applies fluorescence in situ hybridization (FISH) and karyotyping to investigate genetic mutations and chromosomal stability. Dr. Diab is proficient in pharmacogenomics and biomarker discovery, utilizing advanced methodologies such as PCR, RT-PCR, and next-generation sequencing to study genetic variations linked to disease susceptibility and drug responses. Additionally, she has extensive experience in bioinformatics, statistical data analysis, and experimental design for toxicological and epidemiological studies. Her research skills also include working with cell cultures, animal models, and phytochemical screening for natural compounds with therapeutic potential. Through her multidisciplinary expertise, Dr. Diab continues to make significant contributions to the fields of genetics and toxicology.

Conclusion

Dr. Kawthar Abdelaziz Elsayed Mohamed Diab is a highly suitable candidate for the Best Researcher Award based on her extensive research experience, international collaborations, impactful publications, and contributions to genetics and cytology. Strengthening leadership in global projects, increasing citation impact, and expanding industry collaborations could further elevate her profile.

Publications Top Noted

  • Diab, K.A., Fahmy, M.A., Hassan, E.E., Nagy, A.M., Farghaly, A.A., Hassan, E.M., Omara, E.A. (2025). Safety evaluation of ethanolic extract from aerial flowering part of spiny globe thistle (Echinops spinosus) in mice: Phytochemical screening and genotoxicity. Mutation Research – Genetic Toxicology and Environmental Mutagenesis. DOI: 10.1016/j.mrgentox.2025.503854

  • Nagy, A.M., Abdelhameed, M.F., Rihan, S., Diab, K.A., El-Saied, M., Mohamed, S.S., El-Nattat, W.S., Hammam, A.M.M. (2024). Rosemary officinalis extract mitigates potassium dichromate-induced testicular degeneration in male rats: Insights from the Nrf2 and its target genes signaling pathway. Toxicology Reports. DOI: 10.1016/J.TOXREP.2024.101700

  • Abdel-Wahhab, M.A., El-Nekeety, A.A., Hassan, M.E., Diab, K.A., Abdel-Aziem, S.H., Hassan, N.S., Abd El-Gawad, A., Kenawy, M.A., Abou Zeid, A.S. (2024). Bee venom loaded into nanoliposomes efficiently eliminates oxidative damage and improves mRNA expression of inflammatory mediator genes in aflatoxin B1-exposed rats. Journal of Drug Delivery Science and Technology. DOI: 10.1016/J.JDDST.2024.106449

  • Salman, A.S., Diab, K.A., Fahmy, M.A., Hassan, E.M., Hassan, Z.M., Omara, E.A., Farghaly, A.A. (2024). Eucalyptus globulus Essential Oil modulates Genotoxicity and Histological Alterations Induced by Mitomycin C in Mice. Egyptian Journal of Chemistry. DOI: 10.21608/EJCHEM.2024.273311.9399

  • Aboelhamd, A., Diab, K., Ibrahim, A., Konsowa, O., Aboul-Enein, A. (2024). Potential Efficacy of Salvia rosmarinus Extracts as Anticancer, Anti-inflammatory and Antioxidant Characters. Egyptian Journal of Chemistry. DOI: 10.21608/EJCHEM.2024.284714.9628

  • Sallam, M.F., Ahmed, H.M.S., El-Nekeety, A.A., Diab, K.A., Abdel-Aziem, S.H., Sharaf, H.A., Abdel-Wahhab, M.A. (2022). Assessment of the Oxidative Damage and Genotoxicity of Titanium Dioxide Nanoparticles and Exploring the Protective Role of Holy Basil Oil Nanoemulsions in Rats. Biological Trace Element Research. DOI: 10.1007/S12011-022-03228-0

  • Gheraibia, S., Belattar, N., Diab, K.A., Hassan, M.E., El-Nekeety, A.A., Abdel-Aziem, S.H., Hassan, N.S., Abdel-Wahhab, M.A. (2022). Costus speciosus extract protects against the oxidative damage of zearalenone via modulation of inflammatory cytokines, Nrf2 and iNOS gene expression in rats. Toxicon. DOI: 10.1016/J.TOXICON.2022.05.002

  • Sallam, M.F., Ahmed, H.M.S., Diab, K.A., El-Nekeety, A.A., Abdel-Aziem, S.H., Sharaf, H.A., Abdel-Wahhab, M.A. (2022). Improvement of the antioxidant activity of thyme essential oil against biosynthesized titanium dioxide nanoparticles-induced oxidative stress, DNA damage, and disturbances in gene expression in vivo. Journal of Trace Elements in Medicine and Biology. DOI: 10.1016/J.JTEMB.2022.127024

  • Diab, K., El-Shenawy, R., Helmy, N., El-Toumy, S. (2022). Polyphenol Content, Antioxidant, Cytotoxic, and Genotoxic Activities of Bombax ceiba Flowers in Liver Cancer Cells Huh7. Asian Pacific Journal of Cancer Prevention. DOI: 10.31557/APJCP.2022.23.4.1345

  • Diab, K.A., Fahmy, M.A., Hassan, E.M., El-Toumy, S.A. (2022). Evaluation of the cytotoxic, anticancer, and genotoxic activities of Acacia nilotica flowers and their effects on N-methyl-N-nitrosourea-induced genotoxicity in mice. Molecular Biology Reports. DOI: 10.1007/s11033-022-07662-0

Paul Kuwornu | Social Sciences | Best Researcher Award

Dr. Paul Kuwornu | Social Sciences | Best Researcher Award

Australian Centre for Health Services Innovation, Queensland University of Technology, Australia

Dr. Paul Kuwornu is a distinguished researcher specializing in health economics, biostatistics, and applied statistics, currently serving as a Senior Research Fellow at the Australian Centre for Health Services Innovation (AusHSI) at Queensland University of Technology. He holds a Ph.D. in Community Health Sciences from the University of Manitoba, Canada, and has a strong academic foundation in biostatistics, financial engineering, and economics. With extensive experience in health policy research, cost-effectiveness analysis, and patient-centered healthcare evaluations, he has contributed significantly to improving healthcare decision-making. Dr. Kuwornu has secured competitive research funding and authored over 26 peer-reviewed publications in high-impact journals, focusing on chronic disease management, health service utilization, and economic modeling in healthcare. His interdisciplinary expertise, spanning academia, government, and industry, underscores his leadership in advancing data-driven healthcare solutions. His contributions make him a strong candidate for the Best Researcher Award, given his impactful and innovative research in health economics.

Professional Profile

Education

Dr. Paul Kuwornu has a strong academic background in health economics, biostatistics, and applied statistics. He earned his Ph.D. in Community Health Sciences from the University of Manitoba, Canada, where he specialized in health services research, economic evaluations, and statistical modeling. Prior to his doctoral studies, he obtained a Master’s degree in Biostatistics, equipping him with advanced quantitative skills for analyzing healthcare data and policy impacts. Additionally, he holds a degree in Financial Engineering and Economics, providing him with a solid foundation in economic analysis, cost-effectiveness assessments, and healthcare financing. His interdisciplinary education has enabled him to bridge the gap between economic theory and healthcare practice, contributing to innovative research in health services optimization. Dr. Kuwornu’s academic journey reflects a commitment to rigorous research and evidence-based decision-making, positioning him as a leading expert in the field of health economics and biostatistics.

Professional Experience

Dr. Paul Kuwornu has extensive professional experience in health economics, biostatistics, and healthcare research. He has worked as a researcher and consultant in health services optimization, economic evaluations, and statistical modeling. His expertise spans various domains, including healthcare cost analysis, policy impact assessments, and data-driven decision-making. Dr. Kuwornu has collaborated with academic institutions, government agencies, and international organizations, contributing to health policy development and evidence-based interventions. He has also held academic positions, teaching biostatistics and health economics, mentoring students, and leading research projects on healthcare efficiency and accessibility. His work involves the application of advanced statistical methods to analyze healthcare outcomes and cost-effectiveness, ensuring optimal resource allocation. With a strong background in interdisciplinary research, he plays a pivotal role in shaping health policy and improving healthcare delivery systems. His contributions have significantly influenced public health strategies and economic evaluations in the healthcare sector.

Research Interest

Dr. Paul Kuwornu’s research interests lie at the intersection of health economics, biostatistics, and healthcare policy. His work focuses on economic evaluations of healthcare interventions, cost-effectiveness analysis, and health services research. He is particularly interested in optimizing healthcare resource allocation, improving healthcare accessibility, and assessing the financial implications of health policies. His research explores statistical modeling in health outcomes, risk prediction, and decision-making strategies for public health interventions. Dr. Kuwornu also investigates health disparities, social determinants of health, and the economic burden of diseases on healthcare systems. His interdisciplinary approach integrates quantitative methods, data analytics, and policy analysis to drive evidence-based solutions for healthcare sustainability. He actively collaborates with researchers, policymakers, and international organizations to address healthcare inefficiencies and enhance system performance. Through his work, he aims to bridge the gap between economic theory and practical healthcare applications, ultimately contributing to more effective and equitable healthcare delivery.

Award and Honor

Dr. Paul Kuwornu has received numerous awards and honors in recognition of his outstanding contributions to health economics and biostatistics. His accolades include prestigious research grants, fellowships, and academic excellence awards from leading institutions and international organizations. He has been honored for his innovative research in healthcare policy and economic evaluations, earning recognition for his work in optimizing healthcare resource allocation. Dr. Kuwornu has also received commendations for his impactful publications in high-impact journals and his contributions to public health initiatives. His excellence in teaching and mentorship has been acknowledged through various academic awards, reflecting his commitment to nurturing future researchers. Additionally, he has been invited as a keynote speaker at renowned conferences and has served as an expert reviewer for leading scientific journals. These awards and honors underscore his dedication to advancing health economics and policy research, reinforcing his reputation as a distinguished scholar in his field.

Research Skill

Dr. Paul Kuwornu possesses exceptional research skills in health economics, biostatistics, and healthcare policy analysis. His expertise includes advanced quantitative and qualitative research methodologies, econometric modeling, and statistical data analysis. He is proficient in using statistical software such as STATA, SPSS, R, and SAS for data interpretation and policy evaluation. Dr. Kuwornu excels in conducting systematic reviews, meta-analyses, and cost-effectiveness studies to assess healthcare interventions and resource allocations. His ability to develop innovative research frameworks has led to impactful contributions in healthcare financing, economic evaluations, and public health decision-making. He has a strong track record of publishing in high-impact journals, demonstrating his analytical rigor and academic excellence. Additionally, his research skills extend to grant writing, securing funding for interdisciplinary projects, and collaborating with international research teams. His commitment to evidence-based research and policy development makes him a highly respected scholar in the field of health economics and biostatistics.

Conclusion

Dr. Paul Kuwornu is a strong candidate for the Best Researcher Award, given his outstanding contributions to health economics, biostatistics, and healthcare innovation. His interdisciplinary research, international experience, and strong publication record make him a highly deserving nominee. Strengthening his global collaborations, leadership in large-scale funding, and increasing citation impact would further enhance his profile.

Publication Top Noted

Title: An economic evaluation of chronic obstructive pulmonary disease clinical pathway in Saskatchewan, Canada: Data-driven techniques to identify cost-effectiveness among patient subgroups

Authors: J.P. Kuwornu (John Paul), F. Maldonado (Fernando), G. Groot (Gary), A. Reid (Amy), D.D. Marciniuk (Darcy D.), and others

Year: 2024

Citations: 1